What the Infectious Disease Physician Needs to Know About Pegylated Interferon and Ribavirin
出版年份 2013 全文链接
标题
What the Infectious Disease Physician Needs to Know About Pegylated Interferon and Ribavirin
作者
关键词
-
出版物
CLINICAL INFECTIOUS DISEASES
Volume 56, Issue 11, Pages 1629-1636
出版商
Oxford University Press (OUP)
发表日期
2013-02-22
DOI
10.1093/cid/cit074
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Escitalopram for the Prevention of Peginterferon-α2a–Associated Depression in Hepatitis C Virus–Infected Patients Without Previous Psychiatric Disease
- (2013) Martin Schaefer et al. ANNALS OF INTERNAL MEDICINE
- Peginterferon alfa-2a Plus Ribavirin for HIV-HCV Genotype 1 Coinfected Patients: A Randomized International Trial
- (2012) Maribel Rodriguez-Torres et al. HIV CLINICAL TRIALS
- Preliminary Study of Two Antiviral Agents for Hepatitis C Genotype 1
- (2012) Anna S. Lok et al. NEW ENGLAND JOURNAL OF MEDICINE
- Randomised clinical trial: escitalopram for the prevention of psychiatric adverse events during treatment with peginterferon-alfa-2a and ribavirin for chronic hepatitis C
- (2011) R. J. de Knegt et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- The protease inhibitor, GS-9256, and non-nucleoside polymerase inhibitor tegobuvir alone, with ribavirin, or pegylated interferon plus ribavirin in hepatitis C
- (2011) Stefan Zeuzem et al. HEPATOLOGY
- Boceprevir for Untreated Chronic HCV Genotype 1 Infection
- (2011) Fred Poordad et al. NEW ENGLAND JOURNAL OF MEDICINE
- Telaprevir for Previously Untreated Chronic Hepatitis C Virus Infection
- (2011) Ira M. Jacobson et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Ribavirin Pregnancy Registry: Findings after 5 years of enrollment, 2003-2009
- (2010) Susan S. Roberts et al. BIRTH DEFECTS RESEARCH PART A-CLINICAL AND MOLECULAR TERATOLOGY
- Ribavirin potentiates interferon action by augmenting interferon-stimulated gene induction in hepatitis C virus cell culture models
- (2010) Emmanuel Thomas et al. HEPATOLOGY
- Prophylactic Treatment With Escitalopram of Pegylated Interferon Alfa-2a–Induced Depression in Hepatitis C
- (2010) Crisanto Diez-Quevedo et al. JOURNAL OF CLINICAL PSYCHIATRY
- Oral combination therapy with a nucleoside polymerase inhibitor (RG7128) and danoprevir for chronic hepatitis C genotype 1 infection (INFORM-1): a randomised, double-blind, placebo-controlled, dose-escalation trial
- (2010) Edward J Gane et al. LANCET
- ITPA gene variants protect against anaemia in patients treated for chronic hepatitis C
- (2010) Jacques Fellay et al. NATURE
- Predictors of hematological abnormalities in patients with chronic hepatitis C treated with interferon and ribavirin
- (2009) Jagdish S. Nachnani et al. ANNALS OF HEMATOLOGY
- Peginterferon alpha-2a is associated with higher sustained virological response than peginterferon alfa-2b in chronic hepatitis C: Systematic review of randomized trials
- (2009) Tahany Awad et al. HEPATOLOGY
- Telaprevir and Peginterferon with or without Ribavirin for Chronic HCV Infection
- (2009) Christophe Hézode et al. NEW ENGLAND JOURNAL OF MEDICINE
- Peginterferon Alfa-2b or Alfa-2a with Ribavirin for Treatment of Hepatitis C Infection
- (2009) John G. McHutchison et al. NEW ENGLAND JOURNAL OF MEDICINE
- Diagnosis, management, and treatment of hepatitis C: An update
- (2008) Marc G. Ghany et al. HEPATOLOGY
- Venous Thromboembolism and Mortality Associated With Recombinant Erythropoietin and Darbepoetin Administration for the Treatment of Cancer-Associated Anemia
- (2008) Charles L. Bennett JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Incidence of anaemia and impact on sustained virological response in HIV/HCV-coinfected patients treated with pegylated interferon plus ribavirin
- (2008) M. Núñez et al. JOURNAL OF VIRAL HEPATITIS
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started